Clinical Trial Adverse Events and Safety Data
This dataset provides comprehensive, standardized reporting of adverse events and safety data from clinical trials, including event details, severity, regulatory coding, and pharmacovigilance notes. It enables robust safety monitoring, regulatory submissions, and data-driven risk assessments for investigational drugs.
Sample rows
preview · 8 of 100 rows · all 16 columns| adverse_event_idstring | action_takenstring | severity_gradeinteger | serious_adverse_eventboolean | clinical_trial_idstring | subject_idstring | event_start_datedate | event_end_datedate | related_to_study_drugboolean | meddra_codestring | meddra_termstring | outcomestring | report_datedate | reporter_rolestring | safety_monitoring_notesstring | event_descriptionstring |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AE00001 | none | 2 | false | CT2024-001 | SUBJ-1001 | 2024-03-15 | 2024-03-17 | true | 10029205 | Headache | recovered | 2024-03-18 | study nurse | Symptoms resolved without intervention. | Patient experienced mild headache and dizziness after study drug administration. |
| AE00002 | dose reduced | 3 | false | CT2024-002 | SUBJ-1012 | 2024-04-02 | 2024-04-06 | true | 10028813 | Nausea | recovering | 2024-04-07 | investigator | Monitored for dehydration, improved after dose reduction. | Subject reported nausea and vomiting post dose. |
| AE00003 | none | 1 | false | CT2024-003 | SUBJ-1023 | 2024-03-21 | blank | false | 10037844 | Rash | recovering | 2024-03-22 | study nurse | Subject has history of skin allergies. | Mild rash observed on forearms. |
| AE00004 | medication added | 2 | false | CT2024-001 | SUBJ-1004 | 2024-03-28 | 2024-04-01 | false | 10043063 | Dyspnea | recovered | 2024-04-02 | investigator | Prescribed inhaler, symptoms resolved. | Shortness of breath reported during follow-up. |
| AE00005 | medication added | 3 | false | CT2024-002 | SUBJ-1016 | 2024-04-10 | 2024-04-11 | true | 10036638 | Pyrexia | recovered | 2024-04-12 | study nurse | Acetaminophen administered, fever subsided. | Subject developed fever after second dose. |
| AE00006 | hospitalized | 4 | true | CT2024-003 | SUBJ-1025 | 2024-03-25 | 2024-03-28 | true | 10021900 | Abdominal pain | recovered | 2024-03-29 | investigator | Admitted for observation, no surgical intervention needed. | Severe abdominal pain requiring hospitalization. |
| AE00007 | none | 1 | false | CT2024-004 | SUBJ-1031 | 2024-04-18 | blank | false | 10016256 | Fatigue | recovering | 2024-04-19 | study nurse | No intervention needed, monitoring ongoing. | Subject reported mild fatigue during study period. |
| AE00008 | hospitalized | 5 | true | CT2024-001 | SUBJ-1007 | 2024-03-30 | 2024-04-02 | true | 10022117 | Anaphylactic reaction | recovered | 2024-04-03 | investigator | Immediate intervention, patient stabilized. | Patient developed severe allergic reaction, treated in ER. |
| AE00009 | none | 1 | false | CT2024-002 | SUBJ-1013 | 2024-04-04 | 2024-04-06 | true | 10021865 | Injection site reaction | recovered | 2024-04-07 | study nurse | Localized swelling, resolved spontaneously. | Mild injection site reaction. |
| AE00010 | drug discontinued | 4 | true | CT2024-003 | SUBJ-1026 | 2024-03-27 | 2024-03-29 | true | 10012735 | Diarrhea | recovering | 2024-03-30 | investigator | Drug stopped, patient monitored for dehydration. | Severe diarrhea post study drug administration. |
| AE00011 | hospitalized | 3 | true | CT2024-004 | SUBJ-1033 | 2024-04-21 | blank | false | 10007541 | Chest pain | recovering | 2024-04-22 | sponsor | Admitted for cardiac evaluation, no acute findings. | Patient experienced chest pain during exercise. |
| AE00012 | dose reduced | 2 | false | CT2024-001 | SUBJ-1009 | 2024-03-25 | 2024-03-27 | true | 10017947 | Hepatic enzyme increased | recovered | 2024-03-28 | investigator | Monitoring continued, values normalized post dose reduction. | Mild elevated liver enzymes detected. |
| AE00013 | medication added | 2 | false | CT2024-002 | SUBJ-1015 | 2024-04-12 | 2024-04-13 | false | 10022001 | Insomnia | recovering | 2024-04-14 | study nurse | Sleep hygiene counseling provided. | Moderate insomnia reported by subject. |
| AE00014 | none | 1 | false | CT2024-003 | SUBJ-1028 | 2024-03-31 | blank | false | 10003658 | Cough | recovered | 2024-04-01 | study nurse | No medication required. | Patient developed mild cough. |
| AE00015 | hospitalized | 5 | true | CT2024-004 | SUBJ-1036 | 2024-04-25 | 2024-04-27 | true | 10029519 | Neutropenia | recovering | 2024-04-28 | investigator | Hospitalized, G-CSF administered. | Patient experienced severe neutropenia. |
| AE00016 | none | 2 | false | CT2024-001 | SUBJ-1010 | 2024-03-29 | 2024-03-31 | true | 10012666 | Dizziness | recovered | 2024-04-01 | study nurse | Monitoring, resolved within 48 hours. | Subject reported dizziness after morning dose. |
| AE00017 | none | 1 | false | CT2024-002 | SUBJ-1018 | 2024-04-15 | blank | true | 10010774 | Constipation | recovering | 2024-04-16 | investigator | Dietary advice given. | Subject developed mild constipation post medication. |
| AE00018 | medication added | 2 | false | CT2024-003 | SUBJ-1030 | 2024-04-02 | 2024-04-05 | false | 10028411 | Myalgia | recovered | 2024-04-06 | sponsor | NSAIDs prescribed, pain resolved. | Patient developed moderate muscle pain. |
| AE00019 | hospitalized | 5 | true | CT2024-004 | SUBJ-1038 | 2024-04-27 | 2024-04-29 | true | 10041056 | Sepsis | fatal | 2024-04-30 | investigator | Patient expired after ICU admission. | Patient developed severe sepsis. |
| AE00020 | none | 1 | false | CT2024-001 | SUBJ-1011 | 2024-04-01 | 2024-04-05 | false | 10001429 | Anxiety | recovering | 2024-04-06 | study nurse | Referred to counseling. | Patient reported mild anxiety. |
What the 100 rows show
from the 100-row sampleHospitalized (action taken) stands out: 16 of its 16 rows have serious_
- 25%serious_
adverse_ event = true - 2median severity_
grade - 3reporter roles
- 4outcomes
Median 2, from 1 to 5.
- string 10
- integer 1
- date 3
- boolean 2
Columns
16 columns in four groups| column | type | description | example |
|---|---|---|---|
| Text 10 columns | |||
adverse_event_id | string | Unique identifier for each reported adverse eventunique | AE00001 |
clinical_trial_id | string | Identifier for the clinical trial in which the adverse event occurred | CT2024-001 |
subject_id | string | Unique identifier for the subject/patient experiencing the adverse event | SUBJ-1001 |
event_description | string | Detailed description of the adverse event | Patient experienced mild … |
meddra_code | string | MedDRA (Medical Dictionary for Regulatory Activities) code for standardized event classification | 10029205 |
meddra_term | string | MedDRA preferred term for the adverse event | Headache |
action_taken | string | Action taken in response to the adverse event (e.g., dose reduced, drug discontinued, no action)6 values · optional | none |
outcome | string | Outcome of the adverse event (e.g., recovered, ongoing, fatal)recovered · recovering · not recovered · fatal · unknown | recovered |
reporter_role | string | Role of the person reporting the event (e.g., investigator, study nurse, sponsor)investigator · study nurse · sponsor · other · optional | study nurse |
safety_monitoring_notes | string | Additional notes or comments from safety monitoring or pharmacovigilance activitiesoptional | No medication required. |
| Numbers 1 column | |||
severity_grade | integer | Severity grade of the adverse event, typically on a standardized scale (e.g., CTCAE 1-5)1 to 5 | 2 |
| Dates and times 3 columns | |||
event_start_date | date | Date when the adverse event started | 2024-03-15 |
event_end_date | date | Date when the adverse event ended (if applicable)optional | 2024-03-17 |
report_date | date | Date the adverse event was reported | 2024-03-18 |
| True or false 2 columns | |||
related_to_study_drug | boolean | Indicates whether the adverse event is related to the study drug | true |
serious_adverse_event | boolean | Flag indicating if the event qualifies as a Serious Adverse Event (SAE) | false |
Use it for
A healthcare dashboard
The serious_
adverse_ event rate, severity_ grade by action_ taken and a breakdown of clinical_ trial_ id. Excel, Power BI or Tableau. Why do 25 of 100 rows have serious_
adverse_ event = true? A root-cause class exercise
Hand out the rows and one question. The answer is in the data, not in the brief.
- Adverse events100AE000012noneAE000064hospital…AE000085hospital…
A software demo
Believable adverse events with clinical_
trial_ id, subject_ id and event_ start_ date to fill a screen in front of a buyer.
blueprint · clinical-trial-adverse-events-and-safety-data
Behind this dataset
Same schema. As many rows as you need.
These 100 rows came out of a blueprint — 16 columns with generation rules behind each one. Open it in Data Factory to retune a column, add your own, wire in foreign keys, and run it at the size you actually need.
- AE ID unique per adverse event
- Subject ID and treatment arm
- Event term (verbatim) and MedDRA preferred term
- Onset date/time and resolution date/time
- Severity: mild (Grade 1), moderate (2), severe (3), life-threatening (4), death (5)
- CTCAE (Common Terminology Criteria for Adverse Events) grading
- Relatedness: unrelated, unlikely, possible, probable, definite
- Serious AE (SAE) criteria: death, hospitalization, disability, life-threatening
1 credit per row. Preview 20 rows free. Buy rows for the full run.
- Exports
- CSV, JSON, JSONL, Parquet, SQL, Excel, TSV, XML
- Licence
- yours to use, including commercially
- API slug
- clinical-trial-adverse-events-and-safety-data